Grifols (GRFS) Short term Debt (2010 - 2023)
Grifols (GRFS) reported Short term Debt of $124.3 million for Q4 2023, up 7.21% on a YoY basis from $116.0 million in Q4 2022, and up 7.21% quarter-over-quarter from $116.0 million in Q4 2022.
Grifols (GRFS) Short term Debt (2010 - 2023) Analysis & Trends
Grifols has reported Short term Debt for 14 years, with the latest figure at $124.3 million in Q4 2023.
- For the quarter ending Q4 2023, Short term Debt rose 7.21% year-over-year to $124.3 million; the trailing twelve-month figure through Dec 2023 stood at $124.3 million (up 7.21% YoY), and the FY2023 full-year result was $124.3 million, up 7.21% from the prior year.
- Short term Debt for Q4 2023 stood at $124.3 million, up from $116.0 million in the prior quarter.
- The five-year high for Short term Debt was $506.3 million in Q4 2020, with the low at $46.2 million in Q4 2019.
- Historically, Short term Debt has averaged $255.5 million across 5 years, with a median of $245.1 million in 2020.
- Annual changes were most pronounced in 2020 — Short term Debt jumped 995.03% — and 2021, when it tumbled 90.23%.
- Grifols' Short term Debt stood at $46.2 million in 2019, then jumped by 995.03% to $506.3 million in 2020, then plunged by 90.23% to $49.5 million in 2021, then soared by 134.5% to $116.0 million in 2022, then grew by 7.21% to $124.3 million in 2023.
- The last three Short term Debt figures came in at $124.3 million (Q4 2023), $116.0 million (Q4 2022), and $49.5 million (Q4 2021), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn |
| 10 | Grifols | 6.05 Bn | 5.09 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 124.34 Mn |
| Dec 31, 2022 | 115.98 Mn |
| Dec 31, 2021 | 49.46 Mn |
| Dec 31, 2020 | 506.26 Mn |
| Sep 30, 2020 | 373.69 Mn |
| Mar 31, 2020 | 365.85 Mn |
| Dec 31, 2019 | 46.23 Mn |
| Sep 30, 2019 | 462.26 Mn |
| Dec 31, 2018 | 18.56 Mn |
| Sep 30, 2018 | 287.95 Mn |
| Jun 30, 2018 | 244.77 Mn |
| Mar 31, 2018 | 405.38 Mn |
| Dec 31, 2017 | 25.91 Mn |
| Jun 30, 2017 | 163.35 Mn |
| Dec 31, 2016 | 28.20 Mn |
| Sep 30, 2016 | 248.78 Mn |
| Jun 30, 2016 | 243.09 Mn |
| Mar 31, 2016 | 15.11 Mn |
| Dec 31, 2015 | 287.73 Mn |
| Sep 30, 2015 | 280.02 Mn |